Literature DB >> 10587465

Kinetic study of the activation of the neutrophil NADPH oxidase by arachidonic acid. Antagonistic effects of arachidonic acid and phenylarsine oxide.

J Doussiere1, F Bouzidi, A Poinas, J Gaillard, P V Vignais.   

Abstract

The O(2)(-) generating NADPH oxidase complex of neutrophils comprises two sets of components, namely a membrane-bound heterodimeric flavocytochrome b which contains the redox centers of the oxidase and water-soluble proteins of cytosolic origin which act as activating factors of the flavocytochrome. The NADPH oxidase can be activated in a cell-free system consisting of plasma membranes and cytosol from resting neutrophils in the presence of GTPgammaS and arachidonic acid. NADPH oxidase activation is inhibited by phenylarsine oxide (PAO), a sulfhydryl reagent for vicinal or proximal thiol groups. The site of action of PAO was localized by photolabeling in the beta-subunit of flavocytochrome b [Doussière, J., Poinas, A, Blais, C., and Vignais, P. V. (1998) Eur. J. Biochem. 251, 649-658]. Moreover, the spin state of heme b is controlled by interaction of arachidonic acid with the flavocytochrome b [Doussière, J., Gaillard, J., and Vignais, P. V. (1996) Biochemistry 35, 13400-13410]. Here we report that the promoting effect of arachidonic acid on the activation of NADPH oxidase is due to specific binding of arachidonic acid to flavocytochrome b. Elicitation of NADPH oxidase activity by arachidonic acid is in part associated with an increased affinity of flavocytochrome b for O(2), an effect that was counteracted by the methyl ester of arachidonic acid. On the other hand, the affinity for NADPH was not affected by arachidonic acid. We further demonstrate that PAO antagonizes the effect of arachidonic acid on oxidase activation by decreasing the affinity of the oxidase for O(2), but not for NADPH. PAO induced a change in the spin state of heme b, as arachidonic acid does, with, however, some differences in the constraints imposed to the heme. It is concluded that the opposite effects of arachidonic acid and PAO are exerted on the beta-subunit of flavocytochrome b at two different interacting sites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587465     DOI: 10.1021/bi991502w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Single-cell Raman and fluorescence microscopy reveal the association of lipid bodies with phagosomes in leukocytes.

Authors:  Henk-Jan van Manen; Yvonne M Kraan; Dirk Roos; Cees Otto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-07       Impact factor: 11.205

Review 2.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

Review 3.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

4.  Inhibition of NOX2 reduces locomotor impairment, inflammation, and oxidative stress after spinal cord injury.

Authors:  Guzal Khayrullina; Sara Bermudez; Kimberly R Byrnes
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

5.  The dehydrogenase region of the NADPH oxidase component Nox2 acts as a protein disulfide isomerase (PDI) resembling PDIA3 with a role in the binding of the activator protein p67 (phox.).

Authors:  Edna Bechor; Iris Dahan; Tanya Fradin; Yevgeny Berdichevsky; Anat Zahavi; Aya Federman Gross; Meirav Rafalowski; Edgar Pick
Journal:  Front Chem       Date:  2015-02-04       Impact factor: 5.221

Review 6.  Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets.

Authors:  Enric Gutiérrez-Martínez; Remi Planès; Giorgio Anselmi; Matthew Reynolds; Shinelle Menezes; Aimé Cézaire Adiko; Loredana Saveanu; Pierre Guermonprez
Journal:  Front Immunol       Date:  2015-07-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.